Experienced in Collagen VI-Related Myopathy

Beata E. Pyrzak

63A Żwirki I Wigury Street, 
Warsaw, MZ, PL 
Experienced in Collagen VI-Related Myopathy
63A Żwirki I Wigury Street, 
Warsaw, MZ, PL 
OverviewLocationsClinical Research

Overview

Beata Pyrzak practices in Warsaw, Poland. Ms. Pyrzak is rated as an Experienced expert by MediFind in the treatment of Collagen VI-Related Myopathy. Her top areas of expertise are Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Obesity in Children, Hypothyroidism, and Hormone Replacement Therapy (HRT).

Her clinical research consists of co-authoring 69 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Collagen VI-Related Myopathy.

Gender
Female

Locations

63A Żwirki I Wigury Street, Warsaw, MZ 02091, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drugs: LUM-201, rhGH Norditropin® pen
Study Phase: Phase 2

69 Total Publications

A Novel Pathogenic Variant of the AVPR2 Gene Leading to Arginine Vasopressin Resistance Since the Neonatal Period.
A Novel Pathogenic Variant of the AVPR2 Gene Leading to Arginine Vasopressin Resistance Since the Neonatal Period.
Journal: Genes
Published: July 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Pyrzak's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile